RNA News and Press, Avidity Biosciences Inc.

2026-03-05 10:05:27 ET More on iShares Core S&P Small-Cap ETF, Vanguard Small-Cap Index Fund ETF Shares, etc. Read the full article on Seeking Alpha For further details see: Most and least shorted small-to-mid-cap stocks

A look at the top 10 most actives in the United States Direxion Daily Semiconductor Bear 3X Shares (SOXS) rose 4.1% to $1.79 on volume of 729,192,933 shares NVIDIA Corporation (NVDA) fell 4.2% to $177.19 on volume of 311,636,494 shares Ensysce Biosciences Inc. (ENSC) rose 57.8% to $0.6232 o...

A look at the top 10 most actives in the United States Direxion Daily Semiconductor Bear 3X Shares (SOXS) rose 5.2% to $1.8102 on volume of 667,996,363 shares Ensysce Biosciences Inc. (ENSC) rose 55.9% to $0.6157 on volume of 269,188,245 shares OneMedNet Corp (ONMD) rose 69.4% to $1.195 on ...

Atrium Therapeutics Launches with Approximately $270 Million to Advance Novel RNA Medicines for Rare Genetic Cardiomyopathies PR Newswire Spinoff from Novartis AG's acquisition of Avidity Biosciences advances precision cardiology programs using targeted RNA delivery platform Le...

Avidity Biosciences Announces Multiple Upcoming Presentations at 2026 Muscular Dystrophy Association (MDA) Clinical & Scientific Conference Avidity Biosciences Announces Multiple Upcoming Presentations at 2026 Muscular Dystrophy Association (MDA) Clinical & Scientific Conference ...

Avidity Biosciences Announces Intention to Adjourn and Reconvene Special Meeting of Stockholders PR Newswire SAN DIEGO , Feb. 23, 2026 /PRNewswire/ -- Avidity Biosciences, Inc. ("Avidity") (NASDAQ: RNA), a biopharmaceutical company committed to delivering a new class of RNA thera...

The New England Journal of Medicine Publishes Results from Phase 1/2 MARINA® Trial of Delpacibart Etedesiran (del-desiran) for Treatment of Myotonic Dystrophy Type 1 PR Newswire Del-desiran effectively delivered siRNA to muscle, resulting in approximately 40% mean reduction in...

Avidity Biosciences Announces Expected Record Date for Spin-Off PR Newswire SAN DIEGO , Feb. 2, 2026 /PRNewswire/ -- Avidity Biosciences, Inc. ("Avidity") (Nasdaq: RNA), a biopharmaceutical company committed to delivering a new class of RNA therapeutics called Antibody Oligon...

2026-01-30 11:22:30 ET More on related tickers Upwork: A 'Strong Buy' With Aggressive Targets, New AI Offerings (Upgrade) Landstar signals $569M heavy haul record as AI investments accelerate network growth Read the full article on Seeking Alpha For further d...

2026-01-29 22:30:00 ET The following segment was excerpted from the Harbor Small Cap Growth Fund ( HASGX ) Q4 2025 Commentary. ... Read the full article on Seeking Alpha For further details see: Harbor Small Cap Growth Fund Q4 2025 Portfolio Performance